Invention Grant
- Patent Title: Antigen binding proteins
- Patent Title (中): 抗原结合蛋白
-
Application No.: US13037505Application Date: 2011-03-01
-
Publication No.: US09434716B2Publication Date: 2016-09-06
- Inventor: Tejinder Kaur Bhinder , Susannah Karen Ford , Volker Germaschewski , Alan Peter Lewis , Mark Brian Pepys
- Applicant: Tejinder Kaur Bhinder , Susannah Karen Ford , Volker Germaschewski , Alan Peter Lewis , Mark Brian Pepys
- Applicant Address: GB
- Assignee: Glaxo Group Limited
- Current Assignee: Glaxo Group Limited
- Current Assignee Address: GB
- Agent Jason C. Fedon; William T. Han
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07D403/06 ; C07K16/18 ; A61K39/00
Abstract:
The present invention relates to antigen binding proteins, such as antibodies, which bind to serum amyloid P component (SAP), polynucleotides encoding such antigen binding proteins, pharmaceutical compositions comprising said antigen binding proteins and methods of manufacture. The present invention also concerns the use of such antigen binding proteins in the treatment or prophylaxis of diseases associated with amyloid deposition including systemic amyloidosis, local amyloidosis, Alzheimer's disease, and type 2 diabetes.
Public/Granted literature
- US20120225055A1 ANTIGEN BINDING PROTEINS Public/Granted day:2012-09-06
Information query
